Document is current
Any future updates will be listed below
-
Authors
Smidler, Andrea L.
Akbari, Omar S.
-
Funding
Funding for this research was provided by:
NIH (R01AI151004, R01AI151004)
- License Information
-
More Information
Article History
Received: 27 March 2025
Accepted: 19 June 2025
First Online: 3 July 2025
Declarations
:
: Not applicable. The authors consent to the publication of this work.
: Not applicable.
: The authors declare competing interests. ALS co-holds a patent on gene drive technology and IFEGENIA technology. OSA co-holds a patent on pgSIT technology as well as IFEGENIA technology. OSA is also a founder of Agragene and Synvect, with equity interest.
